Home / Cancer and immune system / Nilutamide
ATC L02BB02 · Anti-Androgens
Nilutamide shortage
As of 2 Nov 2026, Nilutamide has a reported shortage in 2 of the 15 countries we track (United States, Canada), covering 3 products from 2 companies.
Countries2/15
Products3packs or presentations
Companies20 listed
Short since18 Sep 20233.1 years ago
Earliest returnnot givencompany estimate
Main reasonNot stated
United States2 products shortCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Timeline
United StatesCanada
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group L02BB · Anti-AndrogensAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Nilandron, Tablet, 150 mg (NDC 59212-111-14) discontinuation | Advanz Pharma (US) Corp. | 1 Dec 2025 | not given | Not stated |
| US | Nilandron, Tablet, 150 mg (NDC 66993-212-38) discontinuation | Advanz Pharma (US) Corp. | 1 Dec 2025 | not given | Not stated |
| CA | ANANDRON (90 tablets (3x30)) | CHEPLAPHARM ARZNEIMITTEL GMBH | 18 Sep 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.